0,852  0,005  Caspase 9 stimulant
0,749  0,004  Tubulin antagonist
0,736  0,005  Cardiovascular analeptic
0,740  0,015  Antineoplastic (breast cancer)
0,733  0,014  Antineoplastic (lung cancer)
0,704  0,014  Antineoplastic (colorectal cancer)
0,695  0,014  Antineoplastic (colon cancer)
0,685  0,007  NOS2 expression inhibitor
0,684  0,009  Aldehyde oxidase inhibitor
0,704  0,030  Apoptosis agonist
0,673  0,003  Alpha tubulin antagonist
0,632  0,015  Prostate cancer treatment
0,618  0,003  Beta tubulin antagonist
0,634  0,020  TNF expression inhibitor
0,621  0,014  Vasodilator, peripheral
0,621  0,015  Antihypercholesterolemic
0,613  0,011  UGT1A9 substrate
0,625  0,028  Transcription factor NF kappa B inhibitor
0,598  0,007  Antimitotic
0,597  0,014  Antineoplastic (cervical cancer)
0,593  0,011  Caspase 3 stimulant
0,577  0,011  Ulceration
0,550  0,018  Antineoplastic (melanoma)
0,550  0,021  Antineoplastic (ovarian cancer)
0,531  0,007  UGT2B4 substrate
0,517  0,004  Pneumotoxic
0,526  0,015  Antineoplastic (non-small cell lung cancer)
0,527  0,019  Antineoplastic (pancreatic cancer)
0,518  0,016  Antineoplastic (multiple myeloma)
0,507  0,010  RNA-directed DNA polymerase inhibitor
0,515  0,018  Antioxidant
0,510  0,014  Antipyretic
0,524  0,035  Antileukemic
0,516  0,028  Antipruritic, allergic
0,497  0,011  Antimutagenic
0,518  0,038  CYP3A4 substrate
0,496  0,022  CTGF expression inhibitor
0,491  0,020  Antineoplastic (glioma)
0,481  0,018  Free radical scavenger
0,467  0,008  Calcium channel activator
0,456  0,008  Antineoplastic (squamous cell carcinoma)
0,461  0,016  UGT1A6 substrate
0,458  0,019  Antineoplastic (glioblastoma multiforme)
0,461  0,029  Hepatic disorders treatment
0,457  0,025  Cytostatic
0,441  0,010  Hepatoprotectant
0,455  0,028  AR expression inhibitor
0,451  0,023  Chemopreventive
0,461  0,034  5 Hydroxytryptamine release stimulant
0,439  0,022  Hypoxia-inducible factor 1 alpha inhibitor
0,421  0,009  Lipid peroxidase inhibitor
0,449  0,038  Teratogen
0,476  0,065  Antineoplastic (solid tumors)
0,445  0,037  Respiratory analeptic
0,420  0,013  UGT1A4 substrate
0,419  0,014  P-glycoprotein inhibitor
0,402  0,008  Tyrosine 3 hydroxylase inhibitor
0,418  0,024  Nitric oxide antagonist
0,417  0,030  Sensitization
0,419  0,033  ICAM1 expression inhibitor
0,410  0,023  Amyloid beta aggregation inhibitor
0,400  0,014  5 Hydroxytryptamine uptake stimulant
0,480  0,096  Antiinflammatory
0,409  0,028  Proliferative diseases treatment
0,397  0,018  Sodium/bile acid cotransporter inhibitor
0,389  0,010  VCAM1 expression inhibitor
0,425  0,050  CYP2C19 inhibitor
0,409  0,035  Lipoxygenase inhibitor
0,386  0,013  UGT1A3 substrate
0,413  0,041  FMO1 substrate
0,407  0,038  Spasmolytic
0,386  0,018  Antineoplastic (sarcoma)
0,391  0,026  Antineoplastic (renal cancer)
0,379  0,014  Antihypotensive
0,383  0,019  Abortion inducer
0,373  0,010  UGT2B15 substrate
0,410  0,047  Cholesterol antagonist
0,425  0,063  Histamine release inhibitor
0,376  0,015  Antiseptic
0,375  0,014  Antineoplastic (carcinoma)
0,417  0,057  Immunosuppressant
0,398  0,038  Cardioprotectant
0,393  0,035  Chemoprotective
0,394  0,037  Vasodilator, coronary
0,397  0,040  Antineoplastic (brain cancer)
0,388  0,037  Cytotoxic
0,361  0,014  Antipruritic, non-allergic
0,349  0,003  UGT2B10 substrate
0,389  0,044  Embryotoxic
0,360  0,016  UGT2B7 substrate
0,357  0,022  UGT1A1 substrate
0,377  0,046  12-Lipoxygenase inhibitor
0,351  0,024  Antineoplastic (bladder cancer)
0,369  0,045  Analeptic
0,348  0,026  Cyclic AMP phosphodiesterase inhibitor
0,359  0,038  DNA damaging
0,345  0,027  UDP-glucuronosyltransferase substrate
0,350  0,033  Vasodilator
0,342  0,026  GST M1-1 substrate
0,331  0,015  Amylase inhibitor
0,326  0,011  Acetylcholinesterase inhibitor
0,327  0,012  Neurotrophic factor enhancer
0,330  0,018  Melanin inhibitor
0,320  0,008  UGT2B9 substrate
0,369  0,058  Antithrombotic
0,359  0,048  CYP2C19 substrate
0,392  0,083  5 Hydroxytryptamine release inhibitor
0,332  0,027  Sedative
0,376  0,071  CYP2C9 substrate
0,341  0,043  Antineoplastic (osteosarcoma)
0,378  0,084  15-Lipoxygenase inhibitor
0,347  0,055  NOS3 expression inhibitor
0,333  0,042  Tumour necrosis factor alpha release inhibitor
0,307  0,016  Genotoxic
0,307  0,017  Antineoplastic (gastric cancer)
0,329  0,040  Transcription factor STAT3 inhibitor
0,296  0,010  Cystathionine beta-synthase inhibitor
0,344  0,059  Apoptosis antagonist
0,321  0,037  Antineoplastic (lymphocytic leukemia)
0,306  0,022  Contraceptive
0,326  0,044  Cardiodepressant
0,372  0,090  Antibacterial
0,298  0,020  Interferon gamma antagonist
0,294  0,019  Cholinergic
0,320  0,046  Antiamyloidogenic
0,318  0,052  CYP1A2 inhibitor
0,348  0,087  GST A substrate
0,280  0,020  Protein kinase stimulant
0,294  0,034  Anesthetic general
0,307  0,048  Antineoplastic (liver cancer)
0,291  0,033  Muscle relaxant
0,331  0,073  Bone diseases treatment
0,316  0,060  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,272  0,016  Antineoplastic (bone cancer)
0,304  0,050  Antidiabetic symptomatic
0,268  0,014  LDLR expression enhancer
0,270  0,017  NADPH oxidase inhibitor
0,314  0,061  Antiosteoporotic
0,253  0,005  Arachidonic acid antagonist
0,299  0,051  Superoxide dismutase inhibitor
0,254  0,008  Microtubule formation inhibitor
0,270  0,026  Skeletal muscle relaxant
0,278  0,036  Antiviral (Influenza)
0,369  0,128  Alpha-glucosidase inhibitor
0,249  0,008  Dopamine D1 antagonist
0,259  0,019  Succinate dehydrogenase inhibitor
0,256  0,019  Heat shock protein 90 antagonist
0,293  0,056  Antiprotozoal (Leishmania)
0,252  0,017  Antifungal enhancer
0,279  0,044  Antihypertriglyceridemic
0,285  0,056  Vascular (periferal) disease treatment
0,266  0,044  Peroxidase inhibitor
0,232  0,011  Choleretic
0,253  0,035  CYP2B6 inhibitor
0,280  0,067  Transcription factor STAT inhibitor
0,226  0,016  Expectorant
0,294  0,085  Antineoplastic (small cell lung cancer)
0,266  0,058  5 Hydroxytryptamine 1E antagonist
0,243  0,037  Nitric-oxide synthase stimulant
0,282  0,077  CYP1A2 substrate
0,229  0,025  VEGF expression inhibitor
0,260  0,056  Antiulcerative
0,291  0,088  Antineoplastic (endocrine cancer)
0,206  0,004  UGT2B11 substrate
0,231  0,030  Antiviral (Influenza A)
0,265  0,068  Hypoglycemic
0,212  0,019  Toll-Like receptor 2 antagonist
0,248  0,055  Carcinogenic
0,205  0,012  Photosensitizer
0,282  0,089  Antifungal
0,212  0,024  Cholesterol synthesis inhibitor
0,237  0,049  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,247  0,060  Psychostimulant
0,203  0,018  Cyclooxygenase 3 inhibitor
0,217  0,032  Toxic, respiratory center
0,238  0,054  Platelet adhesion inhibitor
0,197  0,015  Adenylate cyclase stimulant
0,248  0,067  Antineoplastic (lymphoma)
0,196  0,016  UGT2B1 substrate
0,197  0,019  SULT1A1 substrate
0,216  0,040  Heat shock protein 90 alpha antagonist
0,188  0,013  Antiviral (Influenza B)
0,204  0,029  SULT1A3 substrate
0,206  0,032  Topoisomerase II inhibitor
0,209  0,035  Skin whitener
0,187  0,015  Androgen antagonist
0,226  0,054  Sigma receptor agonist
0,187  0,016  Contraceptive female
0,188  0,017  Antineoplastic alkaloid
0,203  0,034  ATPase inhibitor
0,203  0,034  Antidiarrheal
0,241  0,073  DNA synthesis inhibitor
0,203  0,035  Antirickettsial
0,313  0,146  Calcium channel L-type activator
0,191  0,024  Antihemorrhagic
0,203  0,038  Antidote
0,199  0,035  Carcinogenic, group 1
0,226  0,063  Antialcoholic
0,176  0,014  Prolactin inhibitor
0,188  0,026  Antieczematic
0,188  0,027  5-Lipoxygenase inhibitor
0,168  0,009  Acetylcholine release stimulant
0,194  0,035  Antiprotozoal (Coccidial)
0,232  0,076  Hypolipemic
0,224  0,068  Antineoplastic enhancer
0,248  0,092  Lipoprotein disorders treatment
0,173  0,017  Estrogen antagonist
0,191  0,036  M18 aspartyl aminopeptidase inhibitor
0,180  0,025  Antihelmintic (Trematoda)
0,257  0,103  CYP2D6 substrate
0,172  0,019  Antineoplastic (uterine cancer)
0,213  0,061  Non-steroidal antiinflammatory agent
0,246  0,095  Radioprotector
0,195  0,043  NOS3 expression enhancer
0,203  0,054  Lipocortins synthesis antagonist
0,183  0,034  CF transmembrane conductance regulator agonist
0,308  0,160  Alzheimer's disease treatment
0,167  0,019  Multidrug resistance-associated protein 1 inhibitor
0,161  0,013  Antifungal (Pneumocystis)
0,171  0,024  Alpha 2c adrenoreceptor antagonist
0,169  0,023  Mucolytic
0,150  0,005  Heat shock protein 90 beta antagonist
0,159  0,014  Anabolic
0,209  0,065  Mutagenic
0,163  0,020  Ca2+-transporting ATPase inhibitor
0,195  0,053  Eye irritation, high
0,173  0,031  Alpha 2b adrenoreceptor antagonist
0,153  0,011  Estrogen agonist
0,156  0,014  SULT1E1 substrate
0,166  0,025  Vanilloid 1 agonist
0,167  0,028  Coagulant
0,162  0,024  Sulfotransferase substrate
0,150  0,013  CDC25A inhibitor
0,154  0,019  DOPA decarboxylase inhibitor
0,235  0,101  Radiosensitizer
0,212  0,079  Antiparasitic
0,165  0,032  GST P1-1 substrate
0,137  0,005  Topoisomerase II beta inhibitor
0,183  0,052  Hair growth stimulant
0,274  0,143  Antiprotozoal
0,164  0,033  Pregnane X receptor agonist
0,145  0,014  Aromatase inhibitor
0,139  0,010  Glycine receptor antagonist
0,157  0,029  Antineoplastic antibiotic
0,148  0,020  Antiprotozoal (Toxoplasma)
0,144  0,016  Dopamine agonist
0,182  0,055  Acaricide
0,141  0,017  Contraceptive male
0,173  0,050  Anesthetic
0,138  0,015  HIV-1 integrase (3'-Processing) inhibitor
0,135  0,014  Estrogen receptor alpha antagonist
0,155  0,035  Heat shock protein 70 antagonist
0,176  0,056  Uterine stimulant
0,129  0,011  Granulocyte macrophage colony stimulating factor agonist
0,139  0,021  Histidine decarboxylase inhibitor
0,144  0,029  Alpha 2 adrenoreceptor antagonist
0,162  0,046  Cocaine dependence treatment
0,133  0,018  Keratolytic
0,177  0,063  Phobic disorders treatment
0,233  0,120  FMO3 substrate
0,134  0,021  Estrogen receptor beta antagonist
0,117  0,004  SULT2A1 substrate
0,147  0,035  Butyrylcholinesterase inhibitor
0,116  0,004  Postcoital contraceptive
0,145  0,034  Constipation treatment
0,273  0,163  Antiparkinsonian
0,117  0,007  Estrogen receptor alpha agonist
0,159  0,051  Carcinogenic, group 3
0,184  0,076  Antihelmintic
0,123  0,016  HIV-1 integrase (Strand Transfer) inhibitor
0,174  0,067  Phospholipase C inhibitor
0,119  0,013  Narcotic antagonist
0,247  0,142  Antiprotozoal (Plasmodium)
0,215  0,111  Flavin-containing monooxygenase substrate
0,128  0,025  Paget's disease treatment
0,161  0,059  Antiparkinsonian, tremor relieving
0,145  0,043  Topoisomerase I inhibitor
0,147  0,046  Antitussive
0,197  0,096  Angiogenesis stimulant
0,127  0,028  Topoisomerase II alpha inhibitor
0,106  0,010  Estradiol 17 beta-dehydrogenase inhibitor
0,117  0,022  ATPase (Vacuolar H+) inhibitor
0,137  0,041  TRPA1 agonist
0,111  0,015  Glycine receptor agonist
0,107  0,012  Androgen agonist
0,129  0,035  Creatine kinase inhibitor
0,119  0,025  Restless leg syndrome treatment
0,242  0,149  Stroke treatment
0,185  0,093  Platelet aggregation inhibitor
0,168  0,076  Antipruritic
0,129  0,037  Dementia treatment
0,117  0,026  Inducible nitric-oxide synthase inhibitor
0,135  0,044  Endometrios treatment
0,192  0,101  Antiviral (HIV)
0,135  0,047  Glutathione S-transferase substrate
0,098  0,009  Progesterone antagonist
0,096  0,008  Transcription factor RelA inhibitor
0,215  0,127  Gastrin inhibitor
0,124  0,036  Vascular dementia treatment
0,161  0,075  Prostate disorders treatment
0,158  0,072  Antiviral (Herpes)
0,186  0,099  Antiparkinsonian, rigidity relieving
0,116  0,030  Alpha 2a adrenoreceptor antagonist
0,126  0,040  Electron transport complex I inhibitor
0,128  0,042  AMP-activated protein kinase stimulant
0,096  0,011  Dopamine D2 agonist
0,136  0,054  Alkylator
0,099  0,017  Postmenopausal disorders treatment
0,139  0,058  Antihyperlipoproteinemic
0,140  0,059  Interleukin 4 antagonist
0,091  0,013  Estrogen receptor beta agonist
0,125  0,046  GABA C receptor agonist
0,118  0,040  HIV-1 integrase (Overall Integration) inhibitor
0,140  0,063  Cyclooxygenase 1 inhibitor
0,176  0,100  Insulin sensitizer
0,083  0,007  Ryanodine receptor antagonist
0,108  0,033  Antiviral (Trachoma)
0,145  0,069  Mannose-6-phosphate isomerase inhibitor
0,093  0,018  5 Hydroxytryptamine 2A agonist
0,108  0,033  Interleukin 5 antagonist
0,100  0,025  Estrogen-related receptor beta agonist
0,125  0,052  Carcinogenic, group 2B
0,085  0,014  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,148  0,077  Cytidine deaminase inhibitor
0,109  0,039  Actinic keratosis treatment
0,107  0,037  Ornithine decarboxylase inhibitor
0,195  0,125  Interleukin agonist
0,128  0,060  Growth stimulant
0,101  0,033  Vanilloid agonist
0,106  0,038  Bile acid receptor antagonist
0,075  0,007  Dopamine D5 agonist
0,091  0,024  Antitreponemal
0,076  0,009  Pregnane X receptor antagonist
0,158  0,091  Tumour necrosis factor antagonist
0,102  0,036  NAD(P)H dehydrogenase (quinone) inhibitor
0,099  0,033  Na+ K+ transporting ATPase inhibitor
0,103  0,037  Carbonic anhydrase VI inhibitor
0,103  0,038  Glutamate release inhibitor
0,078  0,012  Dopamine D5 antagonist
0,137  0,072  Neurotrophic factor
0,205  0,141  Antihypoxic
0,101  0,037  Carbonic anhydrase XIII inhibitor
0,145  0,083  Protein-tyrosine phosphatase inhibitor
0,215  0,153  Angiogenesis inhibitor
0,112  0,051  GST T1-1 substrate
0,092  0,031  SULT1A2 substrate
0,151  0,092  Liver fibrosis treatment
0,126  0,067  Gastritis treatment
0,121  0,063  Protein-tyrosine phosphatase 1B inhibitor
0,120  0,062  Monophenol monooxygenase inhibitor
0,153  0,096  3C-like protease (Human coronavirus) inhibitor
0,080  0,023  Antimycoplasmal
0,080  0,023  Aldose reductase inhibitor
0,093  0,038  Antibiotic
0,151  0,096  Dual specificity phosphatase 3 inhibitor
0,073  0,018  Lipocortins synthesis agonist
0,108  0,054  Chronic obstructive bronchitis treatment
0,122  0,068  Antiviral (Hepatitis B)
0,112  0,058  Gout treatment
0,105  0,051  Breast cancer-resistant protein inhibitor
0,132  0,079  Farnesoid X receptor antagonist
0,124  0,072  Papain-like protease (SARS coronavirus) inhibitor
0,125  0,074  Antibacterial (Helicobacter pylori)
0,136  0,086  Hemostatic
0,091  0,042  Dopamine antagonist
0,092  0,043  Opioid kappa receptor antagonist
0,073  0,023  Calcium channel P-type blocker
0,092  0,044  mTOR complex 2 inhibitor
0,065  0,018  Anesthetic inhalation
0,051  0,004  Dopamine D1 agonist
0,076  0,030  Glutamate (mGluR6) antagonist
0,177  0,132  Myocardial infarction treatment
0,074  0,029  Andropause treatment
0,121  0,076  Alpha-N-acetylglucosaminidase inhibitor
0,081  0,037  HIV-1 integrase inhibitor
0,051  0,008  Tubulin agonist
0,092  0,050  Tocolytic
0,108  0,066  GABA C receptor antagonist
0,115  0,074  Alcohol dehydrogenase substrate
0,110  0,069  Myasthenia Gravis treatment
0,096  0,056  Protein kinase C zeta inhibitor
0,082  0,041  MAP kinase kinase 7 inhibitor
0,107  0,066  Protein kinase C gamma inhibitor
0,090  0,050  Antispirochetal
0,055  0,016  Guanylate cyclase inhibitor
0,079  0,040  Dopamine D2 antagonist
0,099  0,060  Xanthine oxidase inhibitor
0,106  0,068  Skin irritative effect
0,071  0,033  Beta 3 adrenoreceptor antagonist
0,166  0,129  Platelet antagonist
0,099  0,063  Carbonic anhydrase III inhibitor
0,178  0,141  Antiprotozoal (Trypanosoma)
0,079  0,045  Glutamate decarboxylase inhibitor
0,072  0,039  Glutamate (mGluR7) antagonist
0,061  0,030  Protein 50S ribosomal subunit inhibitor
0,055  0,024  Factor III inhibitor
0,058  0,027  Prolyl endopeptidase inhibitor
0,040  0,009  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,100  0,069  Toll-Like receptor 4 antagonist
0,132  0,101  Hexokinase inhibitor
0,150  0,119  Sepsis treatment
0,056  0,025  Squalene epoxidase inhibitor
0,049  0,019  5-Alpha-reductase inhibitor
0,042  0,012  Catechol O-methyltransferase inhibitor
0,195  0,165  Insulysin inhibitor
0,144  0,117  Neurotensin receptor agonist
0,086  0,059  Calcium antagonist
0,064  0,038  Transcription factor AP-1 inhibitor
0,118  0,091  Antiprotozoal (Trichomonas)
0,101  0,074  Antifungal (Aspergillus)
0,068  0,041  Beta adrenoreceptor antagonist
0,031  0,005  Progesterone receptor B antagonist
0,056  0,029  Vanilloid 2 antagonist
0,045  0,018  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,222  0,196  CYP2C9 inhibitor
0,042  0,018  Glucocorticoid antagonist
0,055  0,032  5 Hydroxytryptamine 2 agonist
0,114  0,090  Antiviral (Papilloma)
0,083  0,060  D-Ala-D-Ala ligase inhibitor
0,039  0,016  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,046  0,023  Liver X receptor alpha agonist
0,135  0,113  Dual specificity phosphatase inhibitor
0,131  0,110  Antihelmintic (Nematodes)
0,169  0,148  Age-related macular degeneration treatment
0,038  0,017  Melatonin 2 agonist
0,060  0,040  Bcl-xL inhibitor
0,078  0,058  Phosphodiesterase 3A inhibitor
0,099  0,079  GABA receptor agonist
0,143  0,123  Antiarrhythmic
0,049  0,030  Aldosterone antagonist
0,041  0,021  Glutamate (mGluR8) agonist
0,053  0,034  Glucose-6-phosphate translocase inhibitor
0,080  0,061  Ca(v)3.1 blocker
0,137  0,119  DNA methyltransferase I inhibitor
0,139  0,121  Aldehyde oxidase substrate
0,075  0,057  Macrophage migration inhibitory factor inhibitor
0,087  0,069  Antischistosomal
0,141  0,123  Pyruvate kinase inhibitor
0,195  0,178  CYP3A4 inhibitor
0,084  0,067  NADH dehydrogenase inhibitor
0,085  0,068  Alpha adrenoreceptor antagonist
0,084  0,067  Antidote, mercury
0,091  0,075  Nitric-oxide synthase inhibitor
0,064  0,048  Phosphodiesterase III inhibitor
0,103  0,088  Autism spectrum disorders treatment
0,067  0,052  Anticholelithogenic
0,162  0,147  Antiviral (Ebola)
0,099  0,085  5 Hydroxytryptamine 2B antagonist
0,131  0,116  Muscular dystrophy treatment
0,102  0,088  Aldehyde dehydrogenase substrate
0,126  0,112  GABA C receptor rho-2 antagonist
0,100  0,086  DNA polymerase I inhibitor
0,058  0,045  Alpha 2 adrenoreceptor agonist
0,116  0,103  Psychosexual dysfunction treatment
0,020  0,007  NMDA receptor phencyclidine site antagonist
0,052  0,040  Nicotinic alpha3beta2 receptor antagonist
0,139  0,127  DNA methylase inhibitor
0,041  0,029  Kainate receptor agonist
0,041  0,030  Hypogonadism treatment
0,079  0,068  CC chemokine 5 receptor agonist
0,032  0,022  Glutamate (mGluR3) agonist
0,097  0,087  Adenylate cyclase inhibitor
0,075  0,066  Antidote, organophosphates
0,042  0,033  Dihydrofolate reductase inhibitor
0,064  0,055  Elastase 1 inhibitor
0,149  0,141  Histone acetyltransferase inhibitor
0,022  0,014  Estrone sulfatase inhibitor
0,103  0,095  Retinopathy treatment
0,012  0,005  Progesterone receptor A antagonist
0,180  0,172  Prostaglandin dehydrogenase inhibitor
0,025  0,018  Vanilloid 2 agonist
0,027  0,020  Hedgehog signaling activator
0,023  0,016  Prostaglandin F2 alpha agonist
0,069  0,063  GABA aminotransferase inhibitor
0,090  0,084  Glutamate (mGluR7) agonist
0,091  0,085  Beta glucuronidase inhibitor
0,098  0,092  Beta amyloid protein antagonist
0,105  0,099  Antiprotozoal (Amoeba)
0,029  0,023  Nicotinic alpha3beta4 receptor agonist
0,139  0,134  Antiviral (Hepatitis)
0,037  0,032  5 Hydroxytryptamine 2B agonist
0,092  0,087  Antihelmintic (Fasciola)
0,032  0,027  Melatonin receptor 1A agonist
0,043  0,038  Potassium channel Kv1.3 blocker
0,027  0,022  Nicotinic alpha4beta2 receptor agonist
0,078  0,073  Antiviral (Dengue virus)
0,055  0,050  Dopamine D3 antagonist
0,019  0,014  Antibiotic Anthracycline-like
0,030  0,025  ATP citrate lysase inhibitor
0,030  0,026  Melatonin agonist
0,077  0,073  Opioid antagonist
0,021  0,017  GRP78 expression inhibitor
0,032  0,029  HMG CoA reductase inhibitor
0,028  0,025  Prostaglandin D2 agonist
0,155  0,152  Acute neurologic disorders treatment
0,016  0,013  Ileal bile acid transport inhibitor
0,070  0,069  GABA B receptor agonist
0,041  0,040  Sigma receptor antagonist
0,095  0,095  Proteasome inhibitor
0,005  0,005  Transcortin receptor antagonist

